Some Benefits for Decompressive Craniectomy in TBI

This article originally appeared here.
Share this content:
Some Benefits for Decompressive Craniectomy in TBI
Some Benefits for Decompressive Craniectomy in TBI

THURSDAY, Sept. 8, 2016 (HealthDay News) -- For patients with traumatic brain injury and refractory elevated intracranial hypertension, decompressive craniectomy results in lower mortality than medical care, according to a study published online Sept. 7 in the New England Journal of Medicine.

Peter J. Hutchinson, Ph.D., from the University of Cambridge in the United Kingdom, and colleagues randomized 408 patients, aged 10 to 65 years, with traumatic brain injury and refractory elevated intracranial pressure to undergo decompressive craniectomy or receive ongoing medical care.

The researchers observed a significant between-group difference in the Extended Glasgow Outcome Scale (GOS-E) distribution (P < 0.001). GOS-E distributions at six months were: death, 26.9 versus 48.9 percent in the surgical group versus medical group; vegetative state, 8.5 versus 2.1 percent; lower severe disability, 21.9 versus 14.4 percent; upper severe disability, 15.4 versus 8.0 percent; moderate disability, 23.4 versus 19.7 percent; and good recovery, 4.0 versus 6.9 percent. The GOS-E distributions at 12 months were: death, 30.4 versus 52.0 percent; vegetative state, 6.2 versus 1.7 percent; lower severe disability, 18.0 versus 14.0 percent; upper severe disability, 13.4 versus 3.9 percent; moderate disability, 22.2 versus 20.1 percent; and good recovery, 9.8 versus 8.4 percent.

"At six months, decompressive craniectomy in patients with traumatic brain injury and refractory intracranial hypertension resulted in lower mortality and higher rates of vegetative state, lower severe disability, and upper severe disability than medical care," the authors write.

Abstract
Full Text
Editorial

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

ASTRO: No Survival Benefit for Adding EBT to Brachytherapy

ASTRO: No Survival Benefit for Adding EBT to ...

Addition of external beam therapy doesn't improve five-year progression-free survival in prostate cancer

ASTRO: Fewer Side Effects With IMRT in Cervical, Endometrial CA

ASTRO: Fewer Side Effects With IMRT in Cervical, ...

Patients in conventional radiotherapy arm had more high-level adverse events than those in IMRT arm

Many Doctors Reluctant to Reveal Mental Health Issues

Many Doctors Reluctant to Reveal Mental Health Issues

Perceived stigma, fear of career repercussions hinder treatment, study suggests

is free, fast, and customized just for you!

Already a member?

Sign In Now »